General Information of Drug (ID: DMKSPDD)

Drug Name
NT-501 ECT
Indication
Disease Entry ICD 11 Status REF
Glaucoma/ocular hypertension 9C61 Phase 2 [1]
Drug Type
Cell therapy
Cross-matching ID
TTD ID
DLPD74

References

1 ClinicalTrials.gov (NCT02862938) Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration. U.S. National Institutes of Health.